Dr. Falk Pharma Benelux BV (Q4016680): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in es: Adding Spanish translations) |
(Removed claims) |
||||||||||||||
Property / instance of | |||||||||||||||
Property / instance of: Kohesio project / rank | |||||||||||||||
Property / financed by | |||||||||||||||
Property / financed by: European Union / rank | |||||||||||||||
Property / country | |||||||||||||||
Property / country: Netherlands / rank | |||||||||||||||
Property / co-financing rate | |||||||||||||||
| |||||||||||||||
Property / co-financing rate: 50.0 percent / rank | |||||||||||||||
Property / start time | |||||||||||||||
| |||||||||||||||
Property / start time: 19 February 2016 / rank | |||||||||||||||
Property / end time | |||||||||||||||
| |||||||||||||||
Property / end time: 19 February 2017 / rank | |||||||||||||||
Property / beneficiary name (string) | |||||||||||||||
Property / beneficiary name (string): Dr. Falk Pharma Benelux BV / rank | |||||||||||||||
Property / beneficiary | |||||||||||||||
Property / beneficiary: Q4009937 / rank | |||||||||||||||
Property / intervention field | |||||||||||||||
Property / intervention field: Active and healthy ageing / rank | |||||||||||||||
Property / postal code | |||||||||||||||
Property / postal code: 4818CP / rank | |||||||||||||||
Property / fund | |||||||||||||||
Property / fund: European Social Fund / rank | |||||||||||||||
Property / programme | |||||||||||||||
Property / programme: Netherlands - ESF / rank | |||||||||||||||
Revision as of 20:31, 17 January 2022
Project Q4016680 in Netherlands
Language | Label | Description | Also known as |
---|---|---|---|
English | Dr. Falk Pharma Benelux BV |
Project Q4016680 in Netherlands |
Statements
Identifiers
2015EUSF201637
0 references